R4 Draft for Comment

This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R4 R3

V2-0227.vs.xml

Vocabulary Work GroupMaturity Level: N/ABallot Status: Informative

Raw XML (canonical form)

FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines (code=MVX))

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v2-0227"/> 
  <meta> 
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> 
  </meta> 
  <text> 
    <status value="additional"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> Manufacturers of Vaccines (code=MVX)</p> 

      <table class="grid">
        <tr> 
          <td> 
            <b> Code</b> 
          </td> 
          <td> 
            <b> Description</b> 
          </td> 
          <td> 
            <b> Comment</b> 
          </td> 
          <td> 
            <b> Version</b> 
          </td> 
        </tr> 
        <tr> 
          <td> AB
            <a name="AB"> </a> 
          </td> 
          <td> Abbott Laboratories</td> 
          <td> (includes Ross Products Division)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> AD
            <a name="AD"> </a> 
          </td> 
          <td> Adams Laboratories, Inc.</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> ALP
            <a name="ALP"> </a> 
          </td> 
          <td> Alpha Therapeutic Corporation</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> AR
            <a name="AR"> </a> 
          </td> 
          <td> Armour</td> 
          <td> [Inactive--use AVB]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> AVB
            <a name="AVB"> </a> 
          </td> 
          <td> Aventis Behring L.L.C.</td> 
          <td> (formerly Centeon L.L.C.; includes Armour Pharmaceutical Company) [Inactive--use ZLB]
               CDC Changes made on: Feb. 28, 2006</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> AVI
            <a name="AVI"> </a> 
          </td> 
          <td> Aviron</td> 
          <td/>  
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> BA
            <a name="BA"> </a> 
          </td> 
          <td> Baxter Healthcare Corporation</td> 
          <td> [Inactive--use BAH]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> BAH
            <a name="BAH"> </a> 
          </td> 
          <td> Baxter Healthcare Corporation</td> 
          <td> (includes Hyland Immuno, Immuno International AG, and North American Vaccine, Inc.)</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> BAY
            <a name="BAY"> </a> 
          </td> 
          <td> Bayer Corporation</td> 
          <td> (includes Miles, Inc. and Cutter Laboratories)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> BP
            <a name="BP"> </a> 
          </td> 
          <td> Berna Products</td> 
          <td> [Inactive--use BPC]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> BPC
            <a name="BPC"> </a> 
          </td> 
          <td> Berna Products Corporation</td> 
          <td> (includes Swiss Serum and Vaccine Institute Berne)</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> CEN
            <a name="CEN"> </a> 
          </td> 
          <td> Centeon L.L.C.</td> 
          <td> [Inactive--use AVB]</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> CHI
            <a name="CHI"> </a> 
          </td> 
          <td> Chiron Corporation</td> 
          <td> [Inactive--use NOV] includes PowderJect Pharmaceuticals, Celltech Medeva Vaccines and
               Evans Medical Limited CDC Changes made on: July 14, 2006</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> CMP
            <a name="CMP"> </a> 
          </td> 
          <td> Celltech Medeva Pharmaceuticals</td> 
          <td> [Inactive--use NOV] CDC Changes made on: July 14, 2006</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> CNJ
            <a name="CNJ"> </a> 
          </td> 
          <td> Cangene Corporation</td> 
          <td> CDC Changes made on: Feb. 28, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> CON
            <a name="CON"> </a> 
          </td> 
          <td> Connaught</td> 
          <td> [Inactive--use PMC]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> DVC
            <a name="DVC"> </a> 
          </td> 
          <td> DynPort Vaccine Company, LLC</td> 
          <td> CDC Changes made on: July 14, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> EVN
            <a name="EVN"> </a> 
          </td> 
          <td> Evans Medical Limited</td> 
          <td> [Inactive--use NOV] CDC Changes made on: July 14, 2006</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> GEO
            <a name="GEO"> </a> 
          </td> 
          <td> GeoVax Labs, Inc.</td> 
          <td> CDC Changes made on: July 14, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> GRE
            <a name="GRE"> </a> 
          </td> 
          <td> Greer Laboratories, Inc.</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> IAG
            <a name="IAG"> </a> 
          </td> 
          <td> Immuno International AG</td> 
          <td> [Inactive--use BAH]</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> IM
            <a name="IM"> </a> 
          </td> 
          <td> Merieux</td> 
          <td> [Inactive--use PMC]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> IUS
            <a name="IUS"> </a> 
          </td> 
          <td> Immuno-U.S., Inc.</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> JPN
            <a name="JPN"> </a> 
          </td> 
          <td> The Research Foundation for Microbial Diseases of Osaka University</td> 
          <td> (BIKEN)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> KGC
            <a name="KGC"> </a> 
          </td> 
          <td> Korea Green Cross Corporation</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> LED
            <a name="LED"> </a> 
          </td> 
          <td> Lederle</td> 
          <td> [Inactive--use WAL]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> MA
            <a name="MA"> </a> 
          </td> 
          <td> Massachusetts Public Health Biologic Laboratories</td> 
          <td> [Inactive--use MBL]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> MBL
            <a name="MBL"> </a> 
          </td> 
          <td> Massachusetts Biologic Laboratories</td> 
          <td> (formerly Massachusetts Public Health Biologic Laboratories)</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> MED
            <a name="MED"> </a> 
          </td> 
          <td> MedImmune, Inc.</td> 
          <td/>  
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> MIL
            <a name="MIL"> </a> 
          </td> 
          <td> Miles</td> 
          <td> [Inactive--use BAY]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> MIP
            <a name="MIP"> </a> 
          </td> 
          <td> Bioport Corporation</td> 
          <td> (formerly Michigan Biologic Products Institute)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> MSD
            <a name="MSD"> </a> 
          </td> 
          <td> Merck &amp; Co., Inc.</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> NAB
            <a name="NAB"> </a> 
          </td> 
          <td> NABI</td> 
          <td> (formerly North American Biologicals, Inc.)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> NAV
            <a name="NAV"> </a> 
          </td> 
          <td> North American Vaccine, Inc.</td> 
          <td> [Inactive--use BAH]</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> NOV
            <a name="NOV"> </a> 
          </td> 
          <td> Novartis Pharmaceutical Corporation</td> 
          <td> (includes Chiron, PowderJect Pharmaceuticals, Celltech Medeva Vaccines and Evans Limited,
               Ciba-Geigy Limited and Sandoz Limited)</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> NVX
            <a name="NVX"> </a> 
          </td> 
          <td> Novavax, Inc.</td> 
          <td> CDC Changes made on: July 14, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> NYB
            <a name="NYB"> </a> 
          </td> 
          <td> New York Blood Center</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> ORT
            <a name="ORT"> </a> 
          </td> 
          <td> Ortho-Clinical Diagnostics</td> 
          <td> (formerly Ortho Diagnostic Systems, Inc.)</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> OTC
            <a name="OTC"> </a> 
          </td> 
          <td> Organon Teknika Corporation</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> OTH
            <a name="OTH"> </a> 
          </td> 
          <td> Other manufacturer</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> PD
            <a name="PD"> </a> 
          </td> 
          <td> Parkedale Pharmaceuticals</td> 
          <td> (formerly Parke-Davis)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> PMC
            <a name="PMC"> </a> 
          </td> 
          <td> sanofi pasteur</td> 
          <td> (formerly Aventis Pasteur, Pasteur Merieux Connaught; includes Connaught Laboratories
               and Pasteur Merieux) CDC Changes made on: Feb. 28, 2006</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> PRX
            <a name="PRX"> </a> 
          </td> 
          <td> Praxis Biologics</td> 
          <td> [Inactive--use WAL]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> PWJ
            <a name="PWJ"> </a> 
          </td> 
          <td> PowderJect Pharmaceuticals</td> 
          <td> (includes Celltech Medeva Vaccines and Evans Medical Limited) [Inactive--use NOV] CDC
               Changes made on: July 14, 2006</td> 
          <td> added v2.5</td> 
        </tr> 
        <tr> 
          <td> SCL
            <a name="SCL"> </a> 
          </td> 
          <td> Sclavo, Inc.</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> SI
            <a name="SI"> </a> 
          </td> 
          <td> Swiss Serum and Vaccine Inst.</td> 
          <td> [Inactive--use BPC]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> SKB
            <a name="SKB"> </a> 
          </td> 
          <td> GlaxoSmithKline</td> 
          <td> (formerly SmithKline Beecham; includes SmithKline Beecham and Glaxo Welcome)</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> SOL
            <a name="SOL"> </a> 
          </td> 
          <td> Solvay Pharmaceuticals</td> 
          <td> CDC Changes made on: July 14, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> TAL
            <a name="TAL"> </a> 
          </td> 
          <td> Talecris Biotherapeutics</td> 
          <td> (includes Bayer Biologicals) CDC Changes made on: Feb. 28, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> UNK
            <a name="UNK"> </a> 
          </td> 
          <td> Unknown manufacturer</td> 
          <td/>  
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> USA
            <a name="USA"> </a> 
          </td> 
          <td> United States Army Medical Research and Material Command</td> 
          <td/>  
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> VXG
            <a name="VXG"> </a> 
          </td> 
          <td> VaxGen</td> 
          <td> CDC Changes made on: July 14, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
        <tr> 
          <td> WA
            <a name="WA"> </a> 
          </td> 
          <td> Wyeth-Ayerst</td> 
          <td> [Inactive--use WAL]</td> 
          <td> added v2.3</td> 
        </tr> 
        <tr> 
          <td> WAL
            <a name="WAL"> </a> 
          </td> 
          <td> Wyeth-Ayerst</td> 
          <td> (includes Wyeth-Lederle Vaccines and Pediatrics, Wyeth Laboratories, Lederle Laboratories,
               and Praxis Biologics)</td> 
          <td> added v2.3.1</td> 
        </tr> 
        <tr> 
          <td> ZLB
            <a name="ZLB"> </a> 
          </td> 
          <td> ZLB Behring</td> 
          <td> (includes Aventis Behring and Armour Pharmaceutical Company) CDC Changes made on: Feb.
               28, 2006</td> 
          <td> added v2.6</td> 
        </tr> 
      </table> 

    </div> 
  </text> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status">
    <valueString value="External"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/> 
  </extension> 
  <url value="http://hl7.org/fhir/ValueSet/v2-0227"/> 
  <version value="2.8.2"/> 
  <name value="v2 Manufacturers of Vaccines (code=MVX)"/> 
  <status value="active"/> 
  <experimental value="false"/> 
  <publisher value="HL7, Inc"/> 
  <contact> 
    <telecom> 
      <system value="url"/> 
      <value value="http://hl7.org"/> 
    </telecom> 
  </contact> 
  <description value="FHIR Value set/code system definition for HL7 v2 table 0227 ( Manufacturers of Vaccines
     (code=MVX))"/> 
  <immutable value="true"/> 
  <compose> 
    <include> 
      <system value="http://hl7.org/fhir/v2/0227"/> 
    </include> 
  </compose> 
</ValueSet>

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.